**Core Concept**
Insulin Glargine is a type of long-acting insulin analog that provides a steady, basal insulin level for 24 hours. It is designed to mimic the natural, basal insulin secretion in the body, which is released continuously between meals.

**Why the Correct Answer is Right**
Insulin Glargine is a long-acting insulin because it has a modified molecular structure that slows its absorption rate. This modification, known as a "hydrophobic hexadecane" tail, increases its solubility in the subcutaneous tissue and reduces its absorption rate, resulting in a flat, prolonged insulin profile. This allows for once-daily dosing, making it easier for patients to manage their diabetes.

**Why Each Wrong Option is Incorrect**
**Option A:** Insulin Lispro is a rapid-acting insulin analog, designed to mimic the natural insulin response after meals. It has a fast onset and short duration of action, making it unsuitable for basal insulin needs.
**Option B:** Insulin Aspart is also a rapid-acting insulin analog, similar to Insulin Lispro. It has a fast onset and short duration of action, making it unsuitable for basal insulin needs.
**Option D:** Insulin Glulisine is another rapid-acting insulin analog, with a fast onset and short duration of action. It is designed for prandial insulin administration, not basal insulin needs.

**Clinical Pearl / High-Yield Fact**
When choosing an insulin regimen, it's essential to consider the patient's lifestyle, meal patterns, and basal insulin needs. Long-acting insulins like Insulin Glargine can provide a stable, basal insulin level, while rapid-acting insulins like Insulin Lispro can help manage postprandial glucose spikes.

**✓ Correct Answer: C. Insulin Glargine**